Winter Katarzyna, Talar-Wojnarowska Renata, Dąbrowski Andrzej, Degowska Małgorzata, Durlik Marek, Gąsiorowska Anita, Głuszek Stanisław, Jurkowska Grażyna, Kaczka Aleksandra, Lampe Paweł, Marek Tomasz, Nasierowska-Guttmejer Anna, Nowakowska-Duława Ewa, Rydzewska Grażyna, Strzelczyk Janusz, Śledziński Zbigniew, Małecka-Panas Ewa
Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Prz Gastroenterol. 2019;14(1):1-18. doi: 10.5114/pg.2019.83422. Epub 2019 Mar 12.
These recommendations refer to the current management in pancreatic ductal adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely poor prognosis. The recommendations regard diagnosis, surgical, adjuvant and palliative treatment, with consideration given to endoscopic and surgical methods. A vast majority of the statements are based on data obtained in clinical studies and experts' recommendations on PDAC management, including the following guidelines: International Association of Pancreatology/European Pancreatic Club (IAP/EPC), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network (NCCN) and Polish Society of Gastroenterology (PSG) and The National Institute for Health and Care Excellence (NICE) All recommendations were voted on by members of the Working Group of the Polish Pancreatic Club. Results of the voting and brief comments are provided with each recommendation.
这些建议涉及胰腺导管腺癌（PDAC）的当前管理，这是一种具有侵袭性病程和极差预后特征的肿瘤。这些建议涵盖诊断、手术、辅助和姑息治疗，并考虑了内镜和手术方法。绝大多数陈述基于临床研究获得的数据以及专家关于PDAC管理的建议，包括以下指南：国际胰腺病协会/欧洲胰腺俱乐部（IAP/EPC）、美国临床肿瘤学会（ASCO）、欧洲医学肿瘤学会（ESMO）、美国国立综合癌症网络（NCCN）、波兰胃肠病学会（PSG）以及英国国家卫生与临床优化研究所（NICE）。所有建议均由波兰胰腺俱乐部工作组的成员投票表决。每项建议都附有投票结果和简要评论。
